1. Home
  2. Labeler Index
  3. Theratechnologies Inc.
  4. 62064-381
  5. NDC Package Code: 62064-381-04 Egrifta Wr

NDC Package 62064-381-04 Egrifta Wr

Tesamorelin Kit Subcutaneous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
62064-381-04
Package Description:
1 KIT in 1 BOX * 1.3 mL in 1 VIAL (62064-371-01) * 30 mL in 1 BOTTLE
Product Code:
62064-381
Proprietary Name:
Egrifta Wr
Non-Proprietary Name:
Tesamorelin
Usage Information:
EGRIFTA WR is indicated for the reduction of excess abdominal fat in HIV-infected adult patients with lipodystrophy.Limitations of Use:Long-term cardiovascular safety of EGRIFTA WR has not been established. Consider risk/benefit of continuation of treatment in patients who have not had a reduction in visceral adipose tissue.EGRIFTA WR is not indicated for weight loss management as it has a weight neutral effect.There are no data to support improved compliance with anti-retroviral therapies in HIV-positive patients taking EGRIFTA WR.
11-Digit NDC Billing Format:
62064038104
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
Product Type:
Human Prescription Drug
Labeler Name:
Theratechnologies Inc.
Dosage Form:
Kit - A packaged collection of related material.
Administration Route(s):
Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
Sample Package:
No
FDA Application Number:
BLA022505
Marketing Category:
BLA - A product marketed under an approved Biologic License Application.
Start Marketing Date:
07-15-2025
Listing Expiration Date:
12-31-2026
Exclude Flag:
N
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 62064-381-04?

The NDC Packaged Code 62064-381-04 is assigned to a package of 1 kit in 1 box * 1.3 ml in 1 vial (62064-371-01) * 30 ml in 1 bottle of Egrifta Wr, a human prescription drug labeled by Theratechnologies Inc.. The product's dosage form is kit and is administered via subcutaneous form.

Is NDC 62064-381 included in the NDC Directory?

Yes, Egrifta Wr with product code 62064-381 is active and included in the NDC Directory. The product was first marketed by Theratechnologies Inc. on July 15, 2025 and its listing in the NDC Directory is set to expire on December 31, 2026 if the product is not updated or renewed by the manufacturer.

What is the NDC billing unit for package 62064-381-04?

The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units.

What is the 11-digit format for NDC 62064-381-04?

The 11-digit format is 62064038104. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-3-262064-381-045-4-262064-0381-04